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Abstract
Prions are largely contained within the nervous and lymphoid tissue of transmissible spongiform encephalopathy (TSE)
infected animals. However, following advances in diagnostic sensitivity, PrP
Sc, a marker for prion disease, can now be
located in a wide range of viscera and body fluids including muscle, saliva, blood, urine and milk, raising concerns that
exposure to these materials could contribute to the spread of disease in humans and animals. Previously we demonstrated
low levels of infectivity in the liver of sheep experimentally challenged with bovine spongiform encephalopathy. In this
study we show that PrP
Sc accumulated in the liver of 89% of sheep naturally infected with scrapie and 100% of sheep
challenged with BSE, at both clinical and preclinical stages of the disease. PrP
Sc was demonstrated in the absence of obvious
inflammatory foci and was restricted to isolated resident cells, most likely Kupffer cells.
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Introduction
Transmissible spongiform encephalopathies (TSEs) or prion
diseases are a group of fatal neurodegenerative disorders which
include Creutzfeldt–Jakob disease (CJD) and Kuru in humans,
bovine spongiform encephalopathy (BSE) in cattle, scrapie in
sheep and goats and chronic wasting disease (CWD) in deer. The
causative agent is widely believed to be a misfolded isoform of the
normal, ubiquitously expressed cellular protein, PrP
c, that converts
to the pathogenic form (PrP
Sc) and accumulates predominantly in
the central nervous system [1].
Scrapie is endemic in the sheep populations of many countries
throughout the world and has been recognised as a disease entity
for almost 300 years. Sheep scrapie is not directly linked with
human TSEs, although it has been implicated as a possible
putative source of BSE in cattle [2] and remains a natural reservoir
of TSE infection. Since the BSE epidemic, and particularly since
the emergence of variant CJD, scrapie has been more closely
monitored because of the possibility that BSE was transmitted to
sheep [3] via exposure to the same infected feed that disseminated
BSE to cattle. Given the widespread distribution of scrapie
infectivity throughout the ovine carcase [4], the potential risk to
human health of BSE in sheep could be much greater than BSE in
cattle, where there is a more restricted tissue involvement [5,6].
Restrictions on the use of sheep carcases for human consump-
tion currently excludes the skull, together with the brain and eyes,
tonsils and spinal cord of animals over 12 months old and the
spleens and ileum of all sheep (defined by EC Regulation 999/
2001 (Annex V), and enforced in England through Transmissible
Spongiform Encephalopathies (England) Regulations 2010), put in
place specifically to minimise the risk to human health from
putative BSE infection of sheep. However, sheep offal is not
excluded. Previously we demonstrated low levels of infectivity in
the liver of sheep experimentally infected with BSE [7]. Here we
demonstrate biochemical detection of PrP
Sc in the liver of the
majority of sheep tested that were infected with scrapie or BSE.
Results
Detection of PrP
Sc in the liver of sheep naturally infected
with scrapie
The presence of PrP
Sc in the liver of nine sheep exposed to scrapie
was assessed using modified versions of the IDEXX HerdChekBSE-
Scrapie Antigen Test Kit EIA H, the Bio-Rad TeSeE Sheep and
Goat EIAH and the Bio-Rad TeSeEH Western blot (WB) (Figure 1).
All sheep were homozygous VRQ/VRQ (at residues 136, 154, 171
of the prion protein), obtained from a single flock and were aged
between 20 and 30 months. Seven of the nine sheep were showing
clinical signs of disease at the time of post mortem (Table 1) and all
were confirmed scrapie positive following assessment of tissue from
the central nervous system and the lymphoreticular system.
Eight of the nine liver samples gave values above the cut-off
point determined from analysis of livers from scrapie negative
control sheep, for both the IDEXX HerdChek assay (OD range
0.053–0.538) (Figure 1a) and the Bio-Rad EIA (OD range 0.015–
0.059) (Figure 1b). Western blot analysis further confirmed the
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Sc bands (Figure 1c) in the eight livers
positive by the two assays. A band of approximately 30 KDa was
observed in the liver samples with a similar relative molecular mass
to the di-glycosylated band of PrP
Sc observed in samples extracted
from the brain from a scrapie positive sheep (Figure 1c Br). The
intensity of this band varied between individual samples and
mirrored the value obtained for the EIA. A second band was
observed at approximately 22 KDa relative molecular mass which
also varied in intensity between samples. However, this band was
also observed in the negative control and is not likely to be specific
for PrP
Sc. A third band with a faster mobility and with a molecular
mass of approximately 18 KDa was seen in two lanes correspond-
ing to the samples where the intensity of the other bands was
greatest. This band had a similar mobility to the unglycosylated
polypeptide from samples extracted from brain. The PrP
Sc from
the lymph node migrated differently to that from the brain, but the
signature three polypeptide cleavage products were still apparent.
This observation has been reported elsewhere and is likely to be a
result of increased glycosylation [8,9,10].
PrP
Sc was not detected in livers from 15 VRQ/VRQ ewes,
ranging in age from 44–93 months old, sampled from a scrapie-
free flock (Figure 1, negative controls). Further analysis by Western
blot confirmed that PrP
Sc could not be detected in the liver from
unexposed sheep, examples of which are shown in figure1(c).
PrP
Sc in the livers from BSE-infected sheep
The presence of PrP
Sc in the liver of seven sheep challenged
with BSE was assessed using the same diagnostic tests as above
(Figure 2). All sheep were homozygous ARQ/ARQ (at residues
136, 154, 171) of the PrP protein and were aged between 27 and
33 months. Three of the seven sheep were showing early clinical
signs of disease at the time of post mortem (Table 1) and all were
confirmed positive following post mortem diagnostic investigation
of tissue from the central nervous system and the lymphoreticular
system.
All seven ARQ/ARQ sheep orally challenged with BSE gave
values above the cut-off point for both the IDEXX HerdChek
assay (OD range 0.090–0.282) (Figure 2a) and the the Bio-Rad
EIA (OD range 0.021–0.106) (Figure 2b). Western blot analysis
further confirmed the presence of PK resistant PrP
Sc in all seven
liver samples (Figure 2c). These results are consistent with the
previous demonstration that infectivity is present in the liver from
BSE-infected sheep 16 months after challenge as shown by mouse
bioassay [7].
Localisation of PrP
Sc in isolated cells in the liver from
scrapie infected and BSE-challenged ewes
Immunohistochemistry (IHC), using anti-PrP monoclonal anti-
bodyR145,showedPrP
Sc depositions inliver samples from both the
scrapie and BSE infected sheep. Similar IHC patterns of labelling
were also observed with antibodies Bar224, P4 and BG4 (data not
shown). Labelling of PrP
Sc was not observed associated with
hepatocytes but was most commonly associated with cells with
round or slightly flattened basophilic nuclei, putatively identified as
Kupffer cells, which phagocytose spent red blood cells and other
particulate debris from the blood (Figure 3). However, PrP
Sc
Figure 1. Detection of PrP
Sc in the livers of VRQ/VRQ scrapie-infected ewes. Liver samples were taken from 9 (S1–S9) VRQ/VRQ scrapie-
infected ewes and 15 unexposed sheep (neg ctrl) and analysed for PrP
Sc using (a) the IDEXX Herdchek assay (b) the Bio-Rad TeSeE ELISA and (c) and
the Bio-Rad TeSeE Sheep and Goat Western blot. Values are shown as the mean and standard deviations (n=4 or 6). The cut-off points for the assays
are shown (dotted line). BM = biotinylated markers with molecular mass shown in kDa. Mesenteric lymph node (MLN) and brain (Br) from confirmed
scrapie positive sheep are shown as positive controls. Liver from a negative sheep (Con) is also shown.
doi:10.1371/journal.pone.0019737.g001
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phagocytic role, could not be ruled out. At least one section was
examined for each animal and positive cells were detected in all
animals examined, the maximum was 4–5 positive cells per section
but more usually there was 1–3 cells. Detection of positive cells by
IHC mirrored the results seen by both EIA and Western blot. The
absence of obvious inflammatory leucocyte infiltrates in the vicinity
of the PrP
Sc labelled cells indicated that the presence of prion
protein was not likely to be due to localised inflammation.
Discussion
In this study, the presence of PrP
Sc in the liver of sheep, infected
with either scrapie or BSE, was demonstrated by EIA, Western
blot and IHC. Furthermore, PrP
Sc was detected in the livers of
TSE infected sheep in the presence and absence of clinical signs.
The PrP
Sc was localised to isolated cells lining sinusoids that are
most likely to be Kupffer cells. Confirmation of the presence of
PrP
Sc in the liver is consistent with our previous study
demonstrating transmission of infectivity from liver of BSE
challenged sheep to mice [7].
In previous studies PrP
Sc was not detected, by IHC, in the liver
at any stage during BSE infection of orally infected Texel sheep
[11] nor has it been detected in sheep following challenge with
BSE by the intracranial route (Martin Jeffrey, unpublished
observation). The reason for the presence of PrP
Sc in the liver of
some infected sheep and not others is uncertain but host genotype,
agent strain/source, dose and route of challenge may all be
influential.
One possible mechanism for extra-neuronal and extra-lymphatic
deposition of prions may be linked to the secondary inflammatory
conditions of organs, leading to the development of isolated
lymphoid follicles [12]. Using rodent models of chronic inflamma-
tory disease, studies have shown that prion accumulation can occur
in otherwise prion-free organs including the kidney, liver and
pancreas [12]. These observations have been extended to the
mammary gland of sheep [13]. However, the distribution and
pattern of labelling in isolated cells in the liver sinuses is not
consistent with this mechanism. Indeed others have demonstrated
prions in the kidneys of sheep in the absence of inflammatory
conditions and propose that accumulationin the kidney results from
direct exposure to prions in blood [14]. This might suggest similar
mechanisms of PrP
Sc accumulation in liver given that scrapie and
BSE- affected sheep accumulate infectivity in blood during both the
preclinical and clinical stages of the disease [15,16]. Furthermore,
liver is directly supplied by blood leaving the alimentary canal, a
source of prions even at very early stages of natural and
experimental scrapie infection in sheep [17,18,19] In the present
study PrP
Sc labelling was observed only in what were putatively
identified as Kupffer cells. A major function of Kupffer cells is to
clear particulate substances from the blood and this is consistent
with the proposed blood-borne mechanism of accumulation.
Kupffer cells were labelled with all PrP specific antibodies tested
including BG4 which recognises the extreme N terminus of PrP
(data not shown).This indicates that the PrP
Sc in Kupffer cells is
the full length protein and is probably not internalised to lysosomal
compartments. This might indicate distinct trafficking pathways of
prions in this cell type compared with those of neurons, glia and
macrophages, in which the prion protein is mostly truncated or it
may represent sequestered PrP
Sc which does not undergo
translocation to lysosomes.
Sequestration of PrP
Sc in the liver is not likely to contribute to
the natural spread of the disease between sheep although it could
pose a threat to food safety if a zoonotic prion disease, such as
BSE, were identified in the sheep flock. Specified risk material
(SRM) controls are in place across the EU as a precautionary
measure to reduce the risk of BSE-infected meat from sheep from
entering the food chain. SRM in sheep includes the skull, together
Table 1. Details of sheep used in the study.
Sample
number Genotype Experimental status
Age
(months) Clinical signs Lymphoid tissue
S1 VRQ/VRQ Natural scrapie 21 None observed Positive
a
S2 21 None observed Positive
a
S3 30 Positive Positive
a
S4 20 Positive Positive
a
S5 20 Positive Positive
a
S6 22 Positive Positive
a
S7 22 Positive Positive
a
S8 24 Positive Positive
a




(Oral challenge at 6 months of age)
28 None observed Positive
b
B2 27 None observed Positive
b
B3 27 None observed Positive
b
B4 27 None observed Positive
b
B5 29 Early positive Positive
b
B6 30 Early positive Positive
b
B7 33 Early positive not tested
Positive
a represents a positive lymphoid tissue result when assayed by EIA and positive
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months old and the spleens and ileum of all sheep. The SRM
controls require that these parts of the sheep are removed and
destroyed to reduce the theoretical risk of human exposure to a
putative zoonotic infection: it is estimated that the SRM are
responsible for about a third of the possible carcase infectivity.
Sheep offal, however, is not included in these controls and is
consumed from sheep of all ages. However, it should be
highlighted that on-going targeted and scanning surveillance for
sheep and goat TSEs in EU member states has so far not identified
any BSE in sheep [20,21]. Thus it is perceived that the risk to
human health from possible infection of sheep with BSE is low
(Spongiform Encephalopathy Advisory Committee statement
2008).
The finding that PrP
Sc is sequestered in the liver of an
unexpectedly high percentage of VRQ/VRQ sheep naturally
infected with scrapie and of ARQ/ARQ sheep experimentally
challenged with BSE provides further information on the organ
distribution of infectivity in the host. It will also be important to
determine whether host species, genotype and prion strain impact
on prion distribution in extra-neural and extra-lymphatic tissues
using more sensitive diagnostic methods.
Materials and Methods
Animals and tissues
All experiments involving animals carried out within VLA are
supervised by a named Veterinary surgeon as required under UK
legislation and individual experiments are approved by UK
government Home office inspectors (Home Office Project licenses:
PPL70/5782 and PPL70/4495).
Liver samples from nine scrapie infected sheep bearing the PrP
genotype, VRQ/VRQ (at residues 136, 154 and 171 respectively)
Figure 2. Detection of PrP
Sc in the livers of ARQ/ARQ BSE-challenged ewes. Liver samples from 7 (B1–B7) ARQ/ARQ BSE-challenged ewes
and 15 negative control sheep (neg ctrl) were analysed for the presence of PrP
Sc using (a) the IDEXX Herdchek assay (b) the Bio-Rad TeSeE ELISA and
(c) the Bio-Rad TeSeE sheep and goat Western blot. Values are shown as the mean and standard deviations (n=4). The cut-off points of the assays are
shown (dotted line). M = molecular mass markers (kDa). Mesenteric lymph node (MLN) and brain (Br) from confirmed scrapie positive sheep are
shown as positive controls. Liver from a negative sheep (C) is also shown.
doi:10.1371/journal.pone.0019737.g002
Figure 3. Detection of PrP
Sc deposits in the liver by IHC using
mAb R145. Arrow head indicate PrP
Sc deposits in Kupffer cells of a
naturally scrapie infected sheep. Scale bar =25 mm.
doi:10.1371/journal.pone.0019737.g003
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originated from a flock where scrapie is endemic, resulting in the
natural infection of 100% of sheep carrying either the VRQ/VRQ
or ARQ/VRQ PrP genotypes.
Scrapie infection was demonstrated by the detection of PrP
Sc in
the brain by immunohistochemistry (IHC) and by biochemical
analysis; seven of the nine ewes were showing clinical signs of
scrapie at the time of post mortem (Table 1). The sheep ranged in
age from 20 to 30 months and were of mixed breeds; three Welsh
Mountain, two Cheviots and four Polled Dorset/Friesland crosses.
In addition, seven liver samples from ARQ/ARQ Suffolk sheep,
ranging in age from 27 to 33 months of age, orally challenged with
5 g UK BSE-infected bovine brain tissue, were investigated. Three
of these ewes were showing early clinical signs at the time of death
but all were infected with BSE as demonstrated by the presence of
PrP
Sc in the brain (Table 1). All sheep were also examined for
PrP
Sc presence in lymphoid tissue either by IHC or Western blot.
Negative control liver samples (n=15) were also taken from
sheep not previously exposed to scrapie. These were obtained
from a New Zealand derived scrapie-free flock maintained under
strict bio-security. The sheep were age and genotype matched
with the disease-affected sheep where possible. The sheep were
confirmed negative for scrapie by IHC for the presence of PrP
Sc
in the brain. All unfixed liver samples were stored at 280uC prior
to analysis.
ELISA and Western blot analysis
Two methods of on-plate immunoassay were used to detect
PrP
Sc in the liver samples, the Bio-Rad TeSeE sheep and goat
ELISA and the IDEXX herdchek scrapie/BSE antigen EIA.
Sample extraction was carried out according to the manufacturer’s
instructions for the Bio-Rad TeSeE sheep and goat ELISA with
several modifications. In brief, liver tissue was ribolysed to produce
a 20% (w/v) homogenate and digested using Proteinase K.
Following precipitation and centrifugation at 15,000 g for 7
minutes, the pellets were solubilised by incubating at 100uC for 5
minutes in the buffer provided. The reconstituted pellets were
applied to the microtitre plates coated with the first anti-PrP
antibody and the plate reacted for 2 hours at room temperature.
After washing, enzyme conjugate was added and plates were left
for 2 hours at room temperature, the plate was then washed and
100 ml tetramethyl benzidine (TMB) substrate was added for 30
minutes at room temperature in the dark. The reaction was
blocked and the absorbance read at 450 nm and 620 nm.
The ‘‘IDEXX HerdChek scrapie/BSE Antigen EIA Test’’, was
carried out according to the manufacturer’s instructions with some
modifications. The liver samples were homogenised as described
but with the incorporation of a single large (6 mm diameter)
ceramic bead and three agitation cycles at 6.5 rpm each for 45
seconds. The homogenates were cooled between each cycle, mixed
with the working plate diluents and added to the 96-well plate
provided. The plate was agitated for 2.5 hours at room
temperature, washed six times with wash solution 1, a conditioning
buffer was added to each well for 10 minutes and the plate again
washed for a further 3 cycles. Immobilised PrP
Sc on the plate was
detected by incubation with a peroxidase conjugated anti-PrP
antibody and was visualised with TMB substrate. Following
incubation for 15 minutes, the reaction was quenched by the
addition of 1M hydrochloric acid and the absorbance was read at
450 nm and 620 nm.
Setting of threshold values for adapted rapid tests
Negative control livers from 15 VRQ/VRQ or ARQ/ARQ
ewes, ranging in age from 44–93 months old, sampled from a
scrapie-free flock were assayed using the IDEXX HerdChek test
and Bio-Rad TeSeE EIA, using the modifications described above.
These data were used to determine cut-off values for positive
signals. The diagnostic tests have cut-off values that are set by the
manufacturers for brain but in this study cut-off values were
determined to take account of the method modifications and the
different tissue type analysed. Thresholds of 3 standard deviations
above the mean were calculated and values of 0.017 and 0.059
absorbance values were set for the Bio-Rad TeSeE and IDEXX
Herdchek EIAs respectively. These values are lower than those set
by the manufacturer for brain.
For the Western blot analysis sample extraction was carried out
according to the manufacturer’s instructions (Bio-Rad TeSeE
Western Blot). Frozen liver tissue was thawed and ribolysed to give
a 20% (w/v) homogenate. The samples were digested with
Proteinase K and the reaction stopped with kit reagent B.
Following precipitation and centrifugation at 15,000 g for 7
minutes, in accordance with the Bio-Rad TeSeE Western blot
protocol, the pellets were re-suspended in Laemmli sample buffer,
heated at 100uC for 5 minutes and centrifuged at 15,000 g for 15
minutes.
For analysis, 15 ml from each sample were loaded on a 12%
Criterion XT Bis-tris SDS gel (Bio-Rad) and subjected to
electrophoresis in XT-MOPS running buffer (Bio-Rad) at 200 V
for 50 minutes. Proteins were transferred to a PVDF membrane (Bio-
Rad) at 115 V, 60 min using Tris/CAPS transfer buffer (Bio-Rad).
The membranes were incubated for 30 minutes with the kit
blocking solution before incubation for one hour with the primary
PrP antibody, SHA31, and then with goat anti-mouse IgG
antibody conjugated to horseradish peroxidase (Bio-Rad) prior to
visualization by chemiluminescence (ECL; Amersham). The signal
was captured using a Bio-Rad Fluor-S multi-imager.
Immunohistochemistry
Post-mortem liver samples were placed in formal saline for a
minimum of three days before processing and embedding in
paraffin wax. IHC detection of PrP
Sc was performed using rat
MAb R145, raised against a synthetic peptide and specific for
residues 221–233 of bovine PrP (YQRESQA YYQRGA), Bar224
(141–147 of ovine PrP), P4(93–97 of ovine PrP) and BG4 (46–54 of
Bovine PrP). Sections of the paraffin embedded tissues were cut at
4 mm onto charged slides and incubated at 60uC for 30 minutes to
improve adhesion. Sections were de-waxed in xylene, and
rehydrated. Epitope demasking was performed by immersion of
sections for 30 minutes in undiluted formic acid, washing in
running tap water for 15 minutes, followed by autoclaving at
121uC in citrate buffer pH 6.1 (8.8 mM sodium citrate dihydrate,
1.3 mM citric acid in 2 litres purified water). Endogenous
peroxidase was blocked using 3% hydrogen peroxide (100 w/vol)
in methanol, and the washing buffer used throughout the procedure
was tris buffered saline, supplemented with 0.2% tween20 (TBST).
R145 was applied at 2 mg/ml for one hour at room temperature,
with immunodetection performed using biotinylated rabbit anti-rat
IgG (Vector Laboratories) and the avidin-biotin-peroxidase-com-
plex (Vector Elite) technique using diaminobenzidine chromogen
prepared in McIlvane’s citrate buffer. Sections were counterstained
using Mayer’s haematoxylin, then dehydrated, cleared and
mounted in dibutylphthalate in xylene (DPX), before examination
by light microscopy.
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